A man from Utah is currently in remission after doctors used an experimental treatment method that uses the Human Immunodeficiency Virus.


For many years, the patient, Marshall Jensen, traveled around the country, undergoing various unsuccessful surgeries, going through different procedures, and taking numerous treatment solutions that did not work. That is how he came across Penn Medicine's experimental treatment.


The researchers at Penn Medicine in Philadelphia have spent twenty years studying and developing this particular treatment that can kill the cancer in leukemia patients. Using the patient's immune cells or T-cells and a disabled HIV that can introduce new genes into the patient's cells.


The treatment method is known as T-cell immunotherapy and it is basically done by acquiring billions of T-cells from the patient's blood. These T-cells are then reprogrammed or genetically modified in the laboratory to enable the killing off of the malignant cells. The new and modified cells are called CTL018 and they are put back into the patient's body to do the work.


HIV is one of the most notorious sexually-transmitted diseases today, and it is a good thing that doctors are able to find a good use for it. 


People who get infected with HIV are at risk for suffering from various signs and symptoms that can seriously harm and endanger anyone. 


Now that this treatment method has been successful, more cancer patients can hopefully benefit from it in the coming years.